Literature DB >> 15125223

[Molecular markers of various stages of nonsmall cell lung cancer development].

I B Zborovskaia1, A G Tatosian.   

Abstract

Studies performed in the recent decade in the Laboratory of the Regulation of Cell and Virus Oncogenes associated structural and functional defects of several oncogenes and tumor suppressor genes with various stages of non-small-cell lung cancer. High risk of lung cancer was established for carriers of rare alleles of the Hras1 minisatellite, the hypermethylated p16INK4A promoter, and microsatellite defects in chromosome regions 3p12, 3p14.2, 3p22-24, 3p21, 3p25, 9p21, and 17p13. Analysis of the Hras1 minisatellite and microsatellites located in two minimal deletion overlap regions of 1p36 was shown to allow a more reliable prognosis in lung cancer. The results testified again that panels of molecular markers are useful for individual risk assessment, early and differential diagnosis, and prognosis in cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15125223     DOI: 10.1023/b:mbil.0000023733.36982.7d

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  28 in total

1.  Tumour immunology.

Authors:  Thierry Boon; Benoit Van den Eynde
Journal:  Curr Opin Immunol       Date:  2003-04       Impact factor: 7.486

2.  Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

Authors:  K Ishikawa; T Nagase; M Suyama; N Miyajima; A Tanaka; H Kotani; N Nomura; O Ohara
Journal:  DNA Res       Date:  1998-06-30       Impact factor: 4.458

3.  Antifilamin, antivinculin, and antitropomyosin antibodies in myasthenia gravis.

Authors:  T Yamamoto; T Sato; H Sugita
Journal:  Neurology       Date:  1987-08       Impact factor: 9.910

4.  A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.

Authors:  Y T Chen; M J Scanlan; U Sahin; O Türeci; A O Gure; S Tsang; B Williamson; E Stockert; M Pfreundschuh; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  Human cortactin as putative cancer antigen.

Authors:  M A Lagarkova; V E Boitchenko; A A Mescheryakov; U A Kashkarova; S A Nedospasov
Journal:  Oncogene       Date:  2000-10-26       Impact factor: 9.867

Review 6.  p53 Antibodies in the sera of patients with various types of cancer: a review.

Authors:  T Soussi
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

7.  The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40.

Authors:  O Türeci; U Sahin; I Schobert; M Koslowski; H Scmitt; H J Schild; F Stenner; G Seitz; H G Rammensee; M Pfreundschuh
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

8.  Characterization of human colon cancer antigens recognized by autologous antibodies.

Authors:  M J Scanlan; Y T Chen; B Williamson; A O Gure; E Stockert; J D Gordan; O Türeci; U Sahin; M Pfreundschuh; L J Old
Journal:  Int J Cancer       Date:  1998-05-29       Impact factor: 7.396

9.  RAP80, a novel nuclear protein that interacts with the retinoid-related testis-associated receptor.

Authors:  Zhijiang Yan; Yong-Sik Kim; Anton M Jetten
Journal:  J Biol Chem       Date:  2002-06-21       Impact factor: 5.157

10.  Structure and chromosomal localization of the human anti-müllerian hormone type II receptor gene.

Authors:  J A Visser; A McLuskey; T van Beers; D O Weghuis; A G van Kessel; J A Grootegoed; A P Themmen
Journal:  Biochem Biophys Res Commun       Date:  1995-10-24       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.